BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 821572)

  • 1. Diphosphonate therapy in nephrocalcinosis.
    McCredie DA; Powell HR; Rotenberg E
    Br J Urol; 1976 Apr; 48(2):93-100. PubMed ID: 821572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Results of prolonged treatment of Paget's disease of bone with disodium ethane-1-hydroxy-1, 1-diphosphonate (EHDP).
    De Vries HR; Bijvoet OL
    Neth J Med; 1974; 17(6):281-98. PubMed ID: 4280525
    [No Abstract]   [Full Text] [Related]  

  • 3. Calcium balance in children treated with diphosphonates.
    Uttley WS; Belton NR; Syme J; Sheppard H
    Arch Dis Child; 1975 Mar; 50(3):187-90. PubMed ID: 167664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of Paget's disease with diphosphonate (disodium ethydronate)].
    Caniggia A; Gennari C; Guideri R; Vattimo A; Nardi P
    Minerva Med; 1976 Jan; 67(1):1-15. PubMed ID: 814505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of calcium urolithiasis with diphosphonate: efficacy and hazards.
    Bone HG; Zerwekh JE; Britton F; Pak CY
    J Urol; 1979 May; 121(5):568-71. PubMed ID: 220433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proceedings: Treatment of Paget's disease of bone with disodium ethane-1-hydroxy-1,1-diphosphonate.
    de Vries HR; Bijvoet OL; Froeling PG
    J Endocrinol; 1975 Mar; 64(3):51P. PubMed ID: 805820
    [No Abstract]   [Full Text] [Related]  

  • 7. Paget's bone disease treated with diphosphonate and calcitonin.
    Hosking DJ; Bijvoet OL; van Aken J; Will EJ
    Lancet; 1976 Mar; 1(7960):615-7. PubMed ID: 55896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of dichloromethylene diphosphonate, ethane-1-hydroxy-1,1-diphosphonate, and rickets in rats.
    O'Hara JP; Jowsey J; Williams GA
    J Lab Clin Med; 1975 Nov; 86(5):793-802. PubMed ID: 171327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radionuclide uptake studies of bone: a quantitative method of evaluating the response of patients with Paget's disease to diphosphonate therapy.
    Goldman AB; Braunstein P; Wilkinson D; Kammerman S
    Radiology; 1975 Nov; 117(2):365-9. PubMed ID: 809805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical, biological and histological effects of ethane-1-hydroxy 1, 1-diphosphonate (EDHP) in Paget's disease].
    Meunier P; Chapuy MC; Courpron P; Vignon E; Edouard C; Bernard J
    Rev Rhum Mal Osteoartic; 1975 Nov; 42(11):699-705. PubMed ID: 817385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic effects of diphosphonate in primary hyperparathyroidism.
    Kaplan RA; Geho WB; Poindexter C; Haussler M; Dietz GW; Pak CY
    J Clin Pharmacol; 1977 Jul; 17(7):410-9. PubMed ID: 195983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of fluoride and ethane-1-hydroxy-1,1-diphosphonate on bone metabolism in the growing chick.
    Chan MM; Rucker RB; Riggins RS
    J Nutr; 1976 Jun; 106(6):802-11. PubMed ID: 178844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Editorial: Diphosphonate treatment in bone disease.
    Fleisch H; Bonjour JP
    N Engl J Med; 1973 Dec; 289(26):1419-20. PubMed ID: 4201877
    [No Abstract]   [Full Text] [Related]  

  • 14. Contrasting effects of ethane-1-hydroxy-1,1-diphosphonate (EHDP) on the regression of two types of dietary-induced atherosclerosis.
    Wagner WD; Clarkson TB; Foster J
    Atherosclerosis; 1977 Aug; 27(4):419-35. PubMed ID: 407913
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of hydrochlorothiazide on phosphorus during treatment with diphosphonate.
    Recker RR
    Clin Pharmacol Ther; 1975 Sep; 18(3):345-9. PubMed ID: 809224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemical and clinical effects of ethane-1-hydroxy-1,1-diphosphonate in calcium nephrolithiasis.
    Baumann JM; Bisaz S; Fleisch H; Wacker M
    Clin Sci Mol Med; 1978 May; 54(5):509-16. PubMed ID: 108043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [EHDP (ethylidene-1-hydroxy-1,1-diphosphonate) in the treatment of polyosseous Paget disease].
    Kovarik J; Niebauer B; Woloszczuk W; Frühwald F; Kolbe H
    Wien Klin Wochenschr; 1985 Mar; 97(7):311-5. PubMed ID: 3922124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myositis ossificans progressiva. Clinical features of eight patients and their response to treatment.
    Smith R; Russell RG; Woods CG
    J Bone Joint Surg Br; 1976 Feb; 58(1):48-57. PubMed ID: 818090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Letter: Disodium ethane-1-hydroxy-1, 1-diphosphonate(E.H.D.P.) in Paget's disease.
    Fromm G; Schajowicz F; Mautalen CA
    Lancet; 1975 Oct; 2(7936):666. PubMed ID: 52045
    [No Abstract]   [Full Text] [Related]  

  • 20. Proceedings: Some effects of disodium ethane-1-hydroxy-1,1-diphosphonate (EHDP) on calcium metabolism in man.
    Walton RJ; Russell RG; Smith R; Warner G
    Clin Sci Mol Med; 1974 Sep; 47(3):13P-14P. PubMed ID: 4213811
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.